Pacira Pharmaceuticals recalls
Pacira Pharmaceuticals has 4 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 3 Jul 2024. 2 are still ongoing. The most frequent reason is sterility.
Total recalls4since 2013
Last 12 months0reported
Class I00% of total
Ongoing2latest 3 Jul 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why pacira pharmaceuticals is recalled
Product types
Brands
By year
Ongoing pacira pharmaceuticals recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Zilretta (triamcinolone acetonide extended-release recalledZilretta | Pacira Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Drug Vial Label: Zilretta¿ recalled by Pacira PharmaceuticalsZilretta | Pacira Pharmaceuticals | Sterility | Nationwide |
All pacira pharmaceuticals recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Zilretta (triamcinolone acetonide extended-release recalledZilretta | Pacira Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Drug Vial Label: Zilretta¿ recalled by Pacira PharmaceuticalsZilretta | Pacira Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Exparel, Bupivicaine Liposome Injectable Suspension recalledExparel | Pacira Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Exparel (bupivacaine liposome injectable suspension) recalled | Pacira Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.